Nutrition, Inflammation, and Acute Pancreatitis

Table 4

Safety and tolerance of nasogastric tube feeding.

Reference	Total patients	Troublesome diarrhoea; 𝑛, (%)	Tube removal; 𝑛, (%)	Gastric retention 𝑛, (%)	Exacerbation of pain following feeding, 𝑛, (%)	Achievement of nutritional goal	Full tolerance of feeding; 𝑛, (%)^†
Eatock et al. 2000 [76]	26	3 (11.5)	1 (3.8)	3 (11.5)	0 (0)	Not stated	19 (73.1)
Eatock et al. 2005 [58]	27	3 (11.1)	1 (3.7)	0 (0)	2 (7.4)	21 patients (78%); after 60 hours	23 (85.1)
Kumar et al. 2006 [59]	16	4 (25)	1 (6.3)	0 (0)	1 (6.3)	16 patients (100%); by day 7*	11 (68.8)
Eckerwall et al. 2006 [41]	23	0 (0)	0 (0)	3 (13)	Not stated	15 patients (66%); by day 7	20 (86.9)
Singh et al. 2012 [64]	39	4 (10.4)	0 (0)	1 (2.5)	3 (7.7)	Not stated	34 (85.6)
Total	131	14 (10.7)	3 (2.3)	7 (5.3)	6 (4.5)	N/A	107 (82.0)

†Did not require temporary reduction, stoppage, or withdrawal of feeding; *six patients were supplemented by parenteral nutrition during the commencement of feeding. N/A: not available.